Insight Molecular Diagnostics (IMDX) Gross Profit Margin (Quarterly): -202.5%

Insight Molecular Diagnostics, Inc. (IMDX)

2.49 +0.03 (+1.22%) USD | NASDAQ | Nov 06, 16:00

2.50 +0.01 (+0.40%) After-Hours: 20:00

Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.

Date	Value
June 30, 2026	-202.5%
March 31, 2026	-1.89K%
December 31, 2025	-4.13%
September 30, 2025	-162.7%
June 30, 2025	-38.80%
March 31, 2025	40.27%
December 31, 2024	2.86%
September 30, 2024	-233.0%
June 30, 2024	-221.6%
March 31, 2024	-190.3%
December 31, 2023	-37.26%
September 30, 2023	-17.02%
June 30, 2023	-17.28%

Date	Value
March 31, 2023	-118.9%
September 30, 2022	-2.41K%
June 30, 2022	-551.1%
March 31, 2022	-254.7%
December 31, 2021	38.14%
September 30, 2021	-88.01%
June 30, 2021	-19.41%
March 31, 2021	7.03%
December 31, 2020	-42.35%
September 30, 2020	-8.29%
June 30, 2020	-155.2%
March 31, 2020	-981.2%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks